Flerie Investor Relations Material
Latest events
Q1 2025
Flerie
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Flerie
Access all reports
Flerie AB is a Swedish life science investment company that focuses on the biotechnology and pharmaceutical sectors. The company invests in and builds companies with pioneering biotech and pharmaceutical projects, leveraging its network, expertise, and resources to support long-term success. Flerie's investments span early to later-stage ventures, with a global reach in the life sciences industry. Flerie AB is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
FLERIE
Country
🇸🇪 Sweden